Izun Pharmaceuticals
Dr. Den specializes in radiation oncology and conducts innovative research across a broad variety of malignancies. He serves as an Associate Professor and a clinical practitioner at Jefferson University and as Chief Medical Officer of Alpha Tau Medical.
Dr. Den received his medical degree from Harvard Medical School. Today, his focus is on improving the lives of patients suffering from cancer through the incorporation of novel agents with radiation therapy.
This person is not in the org chart
This person is not in any offices
Izun Pharmaceuticals
Izun Pharmaceuticals develops non-steroidal topical oral anti-inflammatory therapies for periodontal treatments.